Teva fined $503M for disparaging a rival and using patents to thwart competition

Taking stock of the drug industry, from the lab to the medicine chest

October 31, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Dan Balilty/AP STAT+ | Teva fined $503 million for disparaging a rival and using patents to thwart competition This marked the second time that the European Commission has successfully concluded a case against a drugmaker for disparaging a rival. By Ed Silverman STAT+ | Two generic drugmakers pay $49 million to settle price-fixing charges The deal is the first time that any of the generic companies have agreement to a settlement with the states over price fixing. By Ed Silverman STAT+ | Wegovy reduces knee pain in osteoarthritis patients with obesity, study finds The GLP-1 drug semaglutide reduced arthritic knee pain in study subjects with high BMI. Further study is needed on the exact mechanism. By Isabella Cueto Photo illustration: Christine Kao/STAT; Photos: Michelle Fredricks, Peggy Peterson, Suzanne Kreiter/Globe Staff STAT+ | These 10 scientists are leading a new generation of gene editors developing CRISPR medicines STAT series looks at movers and shakers in the life sciences. Here are 10 scientists developing new therapeutic applications of CRISPR By Megan Molteni STAT+ | Capricor and the FDA: A daring, risky filing strategy The company is leveraging the precedent set by Sarepta Therapeutics with its plans for a stem cell therapy for patients with Duchenne muscular dystrophy. By Adam Feuerstein STAT+ | To mitigate drug shortages, a new study suggests looking at Canada "One action or policy solution isn't going to solve this problem," said Katie Suda, a professor of medicine at the University of Pittsburgh. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser